Pulmatrix (PULM) Assets Average (2014 - 2026)
Pulmatrix (PULM) posted Assets Average of $4.3 million for Q1 2026, down 5.33% sequentially from $4.6 million in Q4 2025, and down 52.01% YoY from $9.0 million in Q1 2025.
Pulmatrix (PULM) Assets Average (2014 - 2026) Analysis & Trends
Pulmatrix has reported Assets Average for 13 years, with the latest figure at $4.3 million in Q1 2026.
- Quarterly Assets Average fell 52.01% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (down 52.01% YoY) and the FY2025 annual result came in at $7.0 million, down 67.92% from the prior year.
- Assets Average slipped to $4.3 million in Q1 2026 per PULM's latest filing, from $4.6 million in the prior quarter.
- Over five years, Assets Average peaked at $56.6 million in Q1 2022 and troughed at $4.3 million in Q1 2026.
- A 5-year average of $26.6 million and a median of $32.2 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2025: Assets Average grew 4.79% in 2022, then slumped 72.04% in 2025.
- Over 5 years, Assets Average stood at $43.7 million in 2022, then declined by 19.08% to $35.4 million in 2023, then slumped by 69.67% to $10.7 million in 2024, then slumped by 57.48% to $4.6 million in 2025, then slipped by 5.33% to $4.3 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $4.3 million, $4.6 million, and $5.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | 3.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.87 Mn |
| Mar 31, 2026 | 4.32 Mn |
| Dec 31, 2025 | 4.56 Mn |
| Sep 30, 2025 | 5.57 Mn |
| Jun 30, 2025 | 7.10 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 10.73 Mn |
| Sep 30, 2024 | 13.65 Mn |
| Jun 30, 2024 | 23.09 Mn |
| Mar 31, 2024 | 32.17 Mn |
| Dec 31, 2023 | 35.36 Mn |
| Sep 30, 2023 | 34.08 Mn |
| Jun 30, 2023 | 33.73 Mn |
| Mar 31, 2023 | 38.51 Mn |
| Dec 31, 2022 | 43.70 Mn |
| Sep 30, 2022 | 47.92 Mn |
| Jun 30, 2022 | 51.85 Mn |
| Mar 31, 2022 | 56.56 Mn |
| Dec 31, 2021 | 57.28 Mn |
| Sep 30, 2021 | 60.59 Mn |